88 related articles for article (PubMed ID: 2527112)
1. [Short- and medium-term treatment of ventricular hyperkinetic arrhythmia with flecainide].
Gallicchio F; Aragona PL; Chiatto M; Pugliese F; Donnangelo L
Clin Ter; 1989 May; 129(3):173-84. PubMed ID: 2527112
[TBL] [Abstract][Full Text] [Related]
2. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
[TBL] [Abstract][Full Text] [Related]
4. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
[TBL] [Abstract][Full Text] [Related]
6. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
Bluschke V; Breithardt G; Abendroth RR; Seipel L
Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
[TBL] [Abstract][Full Text] [Related]
7. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
Maison-Blanche P; Brembilla-Perrot B; Fauchier JP; Babuty D; Garnier LF; Rouesnel P; Breuillac JC; Funck F; Scheck F; Peraudeau P; Medvedowsky JL
Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
[TBL] [Abstract][Full Text] [Related]
9. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
[TBL] [Abstract][Full Text] [Related]
10. Short QT syndrome: pharmacological treatment.
Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C
J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889
[TBL] [Abstract][Full Text] [Related]
11. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
12. Oral flecainide for the treatment of drug-resistant ventricular ectopy.
Strasberg B; Stein S; Sclarovsky S
Isr J Med Sci; 1990 May; 26(5):258-61. PubMed ID: 1696248
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
[TBL] [Abstract][Full Text] [Related]
14. [Effects of oral flecainide treatment of refractory tachyarrhythmias].
Sakurada H; Hiyoshi Y; Tejima T; Yanase O; Tokuyasu Y; Watanabe K; Motomiya T; Sugiura M; Hiraoka M
Kokyu To Junkan; 1990 May; 38(5):471-6. PubMed ID: 2115193
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of flecainide in the treatment of ventricular tachycardia in the elderly. Dynamic electrocardiographic study].
Filice A; Attanasio A; Capria A; Piccolo CG; Fabrizi E
Clin Ter; 1989 Jun; 129(6):459-64. PubMed ID: 2526707
[TBL] [Abstract][Full Text] [Related]
16. [Flecainide: a new antiarrhythmic agent].
Leclercq JF; Coumel P
Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
[TBL] [Abstract][Full Text] [Related]
17. [Effects of flecainide in patients with non-sustained ventricular tachycardia and impaired left ventricular function].
De Marzio P; Morelli S; Suppa M; Caputo V; Mango L; Guido V; Cardoni F; Gnecchi M; Aguglia F
Minerva Cardioangiol; 1991; 39(1-2):35-9. PubMed ID: 1906997
[TBL] [Abstract][Full Text] [Related]
18. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of patients with mitral valve prolapse presenting with rhythm disturbances.
Piwowarska W; Mroczek-Czernecka D
Ann Clin Res; 1988; 20(6):389-92. PubMed ID: 3218909
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography.
Hwang YS; Wang JL
Clin Ther; 1989; 11(3):392-7. PubMed ID: 2743373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
